Durect Corporation (DRRX)
Add to Watchlists Create an Alert
0.89
-0.02 -2.03%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
Durect Corporation Revenue Quarterly YoY Growth:
-89.92% for March 31, 2013Durect Corporation Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -89.92% |
| Dec. 31, 2012 | -63.49% |
| Sept. 30, 2012 | -52.83% |
| June 30, 2012 | -38.77% |
| March 31, 2012 | 378.7% |
| Dec. 31, 2011 | 5.17% |
| Sept. 30, 2011 | -0.01% |
| June 30, 2011 | 7.11% |
| March 31, 2011 | 12.24% |
| Dec. 31, 2010 | 74.17% |
| Sept. 30, 2010 | -3.13% |
| June 30, 2010 | 49.95% |
| March 31, 2010 | 24.45% |
| Dec. 31, 2009 | -36.86% |
| Sept. 30, 2009 | 26.29% |
| June 30, 2009 | -22.62% |
| March 31, 2009 | -4.32% |
| Dec. 31, 2008 | 17.33% |
| Sept. 30, 2008 | 34.51% |
| June 30, 2008 | -53.07% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
DRRX Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Acura Pharmaceuticals | |
| Pain Therapeutics | -34.14% |
| Hospira | -8.48% |
DRRX Revenue Quarterly YoY Growth Rankings
| Overall |
39th percentile 4854 of 8009 |
| Sector |
27th percentile 498 of 687 in Healthcare |
| Industry |
33rd percentile 46 of 69 in Drug Manufacturers - Specialty & Generic |
DRRX Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -89.92% | Mar 2013 |
| Maximum | 378.7% | Mar 2012 |
| Average | 13.24% |
